The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 30, 2017

Filed:

Sep. 18, 2014
Applicant:

Icu Medical, Inc., San Clemente, CA (US);

Inventors:

Anatoly S. Belkin, Glenview, IL (US);

William K. Day, Hoffman Estates, IL (US);

Steve J. Lindo, Chicago, IL (US);

James P. Roman, Nashotah, WI (US);

Andrei T. Stratan, Mountain View, CA (US);

Assignee:

ICU Medical, Inc., San Clemente, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/142 (2006.01); G06F 19/00 (2011.01);
U.S. Cl.
CPC ...
A61M 5/142 (2013.01); G06F 19/3418 (2013.01); G06F 19/3468 (2013.01); A61M 2005/14208 (2013.01); A61M 2205/17 (2013.01); A61M 2205/35 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01);
Abstract

A fail-safe drug infusion system, including a user interface controller (UIC) and at least one pump motor controller (PMC), with protocols that enable the PMC to operate therapy delivery for a limited amount of time if the UIC fails or the communication link between the UIC and the PMC is interrupted. Includes synchronization methods to synchronize the delivery information back to the UIC after the UIC reboots or after the communication link is restored. The PMC may apply intelligent fail-safe drug infusion therapy by temporarily displaying therapy information, for example information normally displayed by the UIC, while taking control of alarm signaling and providing minimal user control of the therapy until the UIC restores itself, the infusion completes normally, or the user stops the infusion. If the PMC becomes inoperable, the UIC may wait for the PMC to reboot, or attempt to switch infusion channels to provide robust drug infusion.


Find Patent Forward Citations

Loading…